A Pilot Study of a Neural Mobilization Intervention Applied to Older Adults With Chronic Musculoskeletal Pain

A Feasibility and Acceptability Study of a Physical Exercise Program Including Neural Mobilization to Improve Pain, Functional Status, and Physical Performance in Older Adults With Chronic Musculoskeletal Pain

The goal of this pilot study is to evaluate the feasibility of integrating neural mobilization techniques into a multimodal physical exercise program for older adults with chronic musculoskeletal pain. The main questions it aims to answer are:

• What is the average time to assess secondary outcomes for each participant?
• What proportion of participants adhered and/or withdrew from the study at the end of the intervention protocol?
• Are there adverse events/effects associated with the intervention protocol?
• What is the level of approval/satisfaction of the participants in relation to the assessment and intervention protocols?
• What is the impact of the intervention protocol on participants´ pain, function, physical performance, somatosensory function, and nerve excursion (secondary outcomes)?

Participants will be assessed at 3 different moments: initial assessment (T0), at the end of the intervention protocol (8 weeks) (T1) and 3 months after the end of the intervention protocol (T2). The intervention protocol will consist of a multimodal exercise program (with or without integration of neural mobilization techniques) to be carried out over a period of 8 weeks at a frequency of twice a week.

Study Overview

• Status: Completed
• Conditions: Chronic Pain; Older Adults; Chronic Musculoskeletal Pain; Chronic Musculoskeletal Disease
• Intervention / Treatment: Other: Physical Exercise Program; Other: Neural Mobilization

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Portugal
  • Aveiro, Portugal, 3810-193
    • University of Aveiro

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Community-dwelling older adults aged 60 years or older, with primary or secondary chronic musculoskeletal pain in any body site and able to walk independently

Exclusion Criteria:

• Individuals with post-surgical pain as a result of surgery performed in the last 6 months;
• Patients with a self-reported diagnoses of infection diseases, dementia, tumor/cancer, neurodegenerative diseases, stroke, uncontrolled diabetes, or at high risk of developing cardiovascular events;
• Those with physical limitations that make it impossible for them to carry out the intervention protocols independently (e.g., wheelchair user);
• Patients who are receiving another physical therapy intervention to treat their pain.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Control group; The control group will perform a physical exercise program twice a week for a period of 8 weeks.	Other: Physical Exercise Program; The physical exercise program will consist of exercises from three different exercise modalities: aerobic training, balance exercises, and isometric exercises.
Experimental: Experimental group; The experimental group will perform the same physical exercise program performed by participants in the control group, in addition to neural mobilization techniques twice a week for a period of 8 weeks.	Other: Physical Exercise Program; The physical exercise program will consist of exercises from three different exercise modalities: aerobic training, balance exercises, and isometric exercises.; Other: Neural Mobilization; Neural mobilization techniques for the upper and lower quadrants will be actively performed by participants.; Other Names: Neurodynamics

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Dropout and adherence rates	Proportion of participants who adhered and withdrew from the study at the end of the intervention protocol. "Adherence to treatment" will be considered if the participant attends at least 12 sessions (75% of the total scheduled sessions).	T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Adverse events and adverse effects	Proportion of participants that reported adverse events and adverse effects during the intervention protocol.	T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Practicality	The average time taken to assess secondary outcomes for each participant.	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Acceptability	The degree to which participants approve of or are satisfied with the assessment and intervention protocols. Acceptability will be assessed qualitatively through focus groups, where a recorded interview (audio only) will be carried out by the study's main researcher, in order to assess the participants' perception of the study and the intervention protocol.	T1: 8 weeks (post-intervention assessment)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain severity	Brief Pain Inventory (BPI)	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Temporal characteristics of pain	World Health Organization (WHO) Classification - It is a categorical variable with three different possible response categories: Episodic recurrent pain - recurrent pain attacks with pain-free intervals;; Continuous pain - pain is always present;; Continuous with pain attacks - recurrent pain flare-ups as exacerbations of ongoing underlying pain.	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Neuropathic pain components	painDETECT questionnaire - The instrument consists of 4 sections related to: (1) pain intensity in the last 4 weeks; (2) the pain pattern; (3) regions of pain; and (4) presence of neuropathic descriptors. The total score is obtained by adding the scores of the last 3 sections and can vary from 1 to 38. Scores ≤ 12 = the neuropathic mechanism is very unlikely to be present (predominance of the nociceptive mechanism); Scores ≥ 19 = there is a high probability of a predominant neuropathic mechanism; Scores > 12 and < 19 = the presence of a mixed component.	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Pain Catastrophizing	Pain Catastrophizing Scale (PCS) - The instrument has 13 items subdivided into three different subscales: helplessness (items 1, 2, 3, 4, 5, and 12); magnification (items 6, 7, and 13); and rumination (items 8, 9, 10, and 11). All subscales are evaluated on a 5-point Likert scale, from 0 (not at all) to 4 (all the time), where higher scores represent a greater level of catastrophizing.	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Fear of Movement	Tampa Scale for Kinesiophobia - The instrument comprises 13 items rated on a 4-point Likert scale, as follows: (1) strongly disagree; (2) somewhat disagree; (3) somewhat agree; (4) strongly agree. The higher the score, the greater the fear perceived during the execution of the movement.	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Symptoms of Central Sensitization	Central Sensitization Inventory (CSI)	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Pressure Pain Threshold (Thenar region of the right hand; Right calcaneus; Region of greatest pain)	Algometer	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Cold and Warm Perception Threshold ((Thenar region of the right hand; Right calcaneus; Region of greatest pain)	Q-sense	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Lower Limb Strength	Five Times Sit to Stand Test	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Grip Strength	Hand-held dynamometer	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Agility and Dynamic Balance	Timed-Up-And-Go Test	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Nerve excursion (median and tibial nerves)	Ultrasonography - The longitudinal and transverse excursion of the tibial and median nerves will be measured in millimeters using ultrasound images taken during the execution of a joint movement.	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)
Range of Motion (ankle dorsiflexion and wrist extension)	Goniometer	T0: baseline assessment; T1: 8 weeks (post-intervention assessment); T2: 3 months post-intervention (follow-up assessment)

Collaborators and Investigators

• Sponsor: Aveiro University

Study record dates

Study Major Dates

• Study Start (Actual): February 12, 2024
• Primary Completion (Actual): April 12, 2024
• Study Completion (Actual): July 13, 2024

Study Registration Dates

• First Submitted: November 9, 2023
• First Submitted That Met QC Criteria: November 16, 2023
• First Posted (Actual): November 18, 2023

Study Record Updates

• Last Update Posted (Actual): July 16, 2024
• Last Update Submitted That Met QC Criteria: July 13, 2024
• Last Verified: July 1, 2024

More Information

Terms related to this study

• Keywords: elderly; physical therapy; neural mobilization
• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Muscular Diseases; Chronic Pain; Musculoskeletal Pain; Musculoskeletal Diseases
• Other Study ID Numbers: RCT1

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No